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Abbreviations: Chol, cholesterol; DHPC, dihexanoyl-phosphatidylcholine; DMPC, 
dimyristoyl-phosphatidylcholine; DTT, dithiothreitol; EqtII, equinatoxin II; PC, 
phosphatidylcholine; SM, sphingomyelin; StII, sticholysin II; SUV, small unilamellar vesicles 
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Abstract 
 
Equinatoxin II (EqtII), a eukaryotic pore-forming toxin, lyses cell membranes through a 
mechanism involving the insertion of its N-terminal α-helix into the membrane. EqtII pore 
formation is dependent on sphingomyelin (SM), although cholesterol (Chol) and membrane 
microdomains have also been suggested to enhance its activity. We have investigated the 
mechanism of EqtII binding and insertion by using neutron reflection to determine the 
structures of EqtII-membrane assemblies in situ. EqtII has several different modes of binding 
to membranes depending on the lipid composition. In pure dimyristoyl-phosphatidylcholine 
(DMPC) membranes, EqtII interacts weakly and reversibly with the lipid head groups in an 
orientation approximately parallel to the membrane surface. The presence of sphingomyelin 
(SM) gives rise to a more upright orientation of EqtII, but Chol is required for insertion into 
the core of the membrane. Cooling the EqtII-lipid assembly below the lipid phase transition 
temperature leads to deep water penetration and a significant reduction in the extension of the 
protein outside the membrane, indicating that phase-separation plays a role in EqtII pore-
formation. An inactive double-cysteine mutant of EqtII in which the α-helix is covalently 
tethered to the rest of the protein, interacts only reversibly with all the membranes. Releasing 
the α-helix in situ by reduction of the disulphide bridge, however, causes the mutant protein to 
penetrate in DMPC-SM-Chol membranes in a manner identical to the wild-type protein. Our 
results help clarify the early steps in pore formation by EqtII and highlight the valuable 
information on protein-membrane interactions available from neutron reflection 
measurements. 
 
 
Keywords: Equinatoxin II, Pore formation, Neutron reflection, Sphingomyelin, Cholesterol, 
Deuteration 
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1. Introduction 
 Equinatoxin II and other actinoporins are highly basic 20-kDa proteins that display 
cytolytic activity in model lipid and cell membranes that is markedly enhanced by 
sphingomyelin (SM) [1-3]. They differ from other classes of bacterial pore-forming toxins [4] 
in that they are smaller, more potent, stable to proteolytic degradation, and form a pore that 
does not have a stable structure and that has not yet been visualized directly [5]. Actinoporin 
pores have a radius of about 1 nm [6-9] and are permeable to small molecules and solutes, 
with the resulting osmotic imbalance promoting cell lysis. These oligomeric pores formed in 
various lipid membranes have been reported to consist of three or, more likely, four 
monomers [6, 10-12]. Tetramers of the actinoporin sticholysin II (StII) have been observed 
both in solution [7] and when crystallized on lipid monolayers [13]. Crystallographic and 
cryo-EM studies of fragaceatoxin C, in contrast, suggested that this actinoporin formed 
octameric or nonameric pore structure [14, 15], but it remains to be seen if these observations 
apply to other members of this family. 
 
 SM plays a key role in the lytic activity of the actinoporins. The haemolytic activity of an 
actinoporin from Stichodactyla helianthus is inhibited by pre-incubation with SM, and 
treatment of erythrocyte membranes with sphingomyelinase renders them resistant to lysis 
[16, 17]. More recent studies with sticholysins I [10] and II [18] on model membranes 
confirmed that SM in the membrane enhances lytic activity and suggested that Chol may have 
a minor role [18]. The haemolytic activity of tenebrosin C[19], which was isolated from the 
Australian red waratah sea anemone Actinia tenebrosa and proved to be identical to 
equinatoxin II (EqtII) from Actinia equina L. [20, 21], was also inhibited by pre-incubation 
with SM [22]. The molecular details of the interaction of EqII with SM [23] have been 
studied extensively [24]. Direct binding assays employing lipid dot blots and surface plasmon 
resonance experiments showed that EqtII specifically recognizes SM but not other lipids. The 
presence of SM in membranes improved both the binding and permeabilizing activity of EqtII 
[24]. Analysis of the interfacial binding site predicted that the two most important residues for 
SM recognition are Trp112 and Tyr113, and that electrostatic interactions play a minor role in 
membrane interactions [24, 25]. A similar association of SM with the head group binding site 
was recently proposed for StII based on binding assays employing SM analogues and 
molecular modelling [25]. 
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 The structure of EqtII [26] solved in solution [27, 28] and by X-ray crystallography [29], 
consists of two short helices packed against opposite faces of a -sandwich structure formed 
by two five-stranded -sheets. Several approaches have been pursued in an effort to elucidate 
the molecular mechanism of pore formation by actinoporins. Small increases in the β-sheet 
and α-helical content of EqtII in unilamellar vesicles were detected by CD and FTIR [8, 30, 
31]. The N-terminal region (residues 10-28) [32, 33] and the surface aromatic cluster 
including Trp112 and 116 were found to embed in lipid membranes [32, 34, 35]. Based on 
these findings, it has been proposed that EqtII binds to membranes initially via the aromatic 
residues, followed by interaction of the N-terminus with the lipid membrane surface [36] and 
finally translocation across the bilayer [37] to form a functional pore [38, 39]. 
 
 Despite considerable progress in understanding EqtII-lipid interactions, the structural 
details of the EqtII-membrane assembly during the pore formation process are not well 
understood. Neutron reflection [40] allows the depth of proteins [41] or nucleic acids [42, 43] 
to be determined in supported planar membranes on the nanometre scale [44], as well as the 
structural changes induced in the membrane in situ. In addition, selective deuterium labelling 
of the lipids allows the membrane composition to be determined directly and related to the 
protein activity [45]. Neutron reflection has been used to elucidate the structure of membrane 
protein-receptor complexes [46], toxin penetration [47] and ion channel structure [48] in 
membranes. In this study we use neutron reflection to investigate the initial binding 
mechanism of EqtII to membranes containing SM and Chol. We show that, while wild-type 
EqtII is able to associate with pure DMPC membranes, its orientation changes in the presence 
of SM, and Chol is required for deep penetration of the protein into the hydrophobic core of 
the membrane. The deep penetration into SM- and Chol-containing membranes occurs at lipid 
compositions outside the domain coexistence region without observable open pore formation, 
consistent with the role proposed for lipid domains in pore formation. In contrast, an oxidized 
double-cysteine mutant of EqtII, in which the dissociation of the α-helix from the β-sandwich 
is prevented [35, 39] binds to membranes in a partly reversible manner, and shows no 
penetration until the α-helix is released in situ by the reducing agent dithiothreitol (DTT). 
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2. Materials and methods 
2.1. Materials 
 Chain deuterated 1,2-D54-dimyristoyl-sn-glycero-3-phosphocholine (D54-DMPC), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), egg sphingomyelin (SM), and cholesterol 
(Chol) were purchased from Avanti Polar Lipids (Alabaster, AL), Tris-HCl, NaCl and DTT 
were from Sigma Aldrich and D2O (>99%) was provided by the Institut Laue Langevin, 
Grenoble. 
 
2.2. Expression and Purification of Proteins 
 Wild-type EqtII and the double cysteine mutant EqtII
V8C,K69C
 (in which residues at positions 
8 and 69 are replaced by cysteine) were expressed in E. coli [35, 49]. E. coli growth in a 
100% D2O medium combined with a fully deuterated carbon source allows the expression of 
fully (100%) perdeuterated recombinant proteins in a reproducible and predictable manner 
[50]. Optimization of the soluble expression level and large scale production of fully 
deuterated recombinant EqtII and EqtII
V8C,K69C
 was carried out in the ILL-EMBL deuteration 
laboratory [51, 52] using the same protocol as recombinant myoglobin, for which the 
deuteration level was shown to be very close to 100% by mass spectroscopy [53]. E. coli 
BL21(DE3) was transformed with a pT7-7 based expression vector coding for the wild-type 
or EqtII
V8C,K69C
 [35]. Cells were grown in deuterated minimal medium with perdeuterated D8-
glycerol (Euriso-Top, France) as a carbon source; adaptation of BL21(DE3) cells to 
deuterated minimal medium was achieved by a multi-stage adaptation process [54]. 1.5 L of 
deuterated medium was inoculated with 100 mL culture of adapted cells in a 3 L fermenter 
(Labfors, Infors). During the batch and fed-batch phases the pH was adjusted to 6.9 (by 
addition of NaOD) and the temperature was adjusted to 30 °C. The gas-flow rate of sterile-
filtered air was 0.5 L min
-1
. Stirring was adjusted to ensure a dissolved oxygen tension of 30 
%. The fed-batch phase was initiated when the optical density at 600 nm reached 3.2. D8-
glycerol was added to the culture to keep the growth rate stable during fermentation. When 
OD600 reached 13 (10.5 for the mutant), protein expression was induced by the addition of 1 
mM IPTG and incubation continued for 24 h. Cells were harvested at an OD600 of 16, washed 
with 10 mM HEPES (pH 6.4), and stored at -80 °C. About 60 g of perdeuterated cell paste 
was obtained for each of the expression constructs. Proteins were purified from the cells as 
described previously [35, 49]. 
 
2.3. Protein purity and activity 
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 The quality of the protein preparations was verified by SDS-PAGE (Fig. S1, 
Supplementary material). The activities of the deuterated and non-deuterated wild-type 
proteins were virtually identical, as measured by haemolysis of bovine erythrocytes. The 
oxidised from of the double cysteine mutant EqtII
V8C,K69C
 (EqtII
V8C,K69C
O) showed no activity 
towards erythrocytes, but the reduced form (EqtII
V8C,K69C
R) shows full activity (Fig. S2, 
Supplementary material). 
 
2.4. Supported membrane formation 
 The support surfaces (single crystal silicon cut along the (111) crystal plane) were cleaned 
for 15 min in a 1:4:5 solution of H2O2:H2SO4:H2O at 80 ºC followed by UV ozonolysis for 5-
10 min before the experiment. This treatment generates a highly hydrophilic SiO2 layer of 7-
15 Å thickness and 3-8 Å surface roughness [55]. 
 
 Small unilamellar vesicles (30-50 nm) were prepared by sonication as described previously 
[45, 56]. In brief, lipid suspensions in chloroform were mixed in appropriate ratios and the 
solvent was then evaporated under a stream of N2. The resulting dry lipid films were 
suspended in 100 mM NaCl in D2O at a concentration of 0.5 mg/mL and incubated for at least 
30 min at 45 °C before sonication. Sonication was performed with a tip sonicator until a clear 
solution was obtained, typically over 8-12 min with a 50% duty cycle (15 s on/off). 
 
 Supported phospholipid bilayers were formed by vesicle fusion to a silicon substrate pre-
heated to 55 °C with an incubation period of 20-30 min prior to rinsing off the excess vesicles 
with 100 mM NaCl, followed by rinsing in 10 mM Tris buffer (pH 7.4) and cooling to 30 °C. 
All protein adsorption experiments were carried out at 30 °C unless otherwise specified. 
 
2.5. Neutron reflection 
 Specular neutron reflection [40] was measured on the D17 reflectometer [57] at the Institut 
Laue Langevin, Grenoble, using neutron wavelengths λ of 2-20 Å to record reflectivity R = 
I0/IR profiles between 0.01 < Q < 0.25 Å
-1, where Q = 4πsinӨ/λ is the momentum transfer 
vector of the neutrons in the direction (z) perpendicular to the membrane-water interface, and 
the reflectivity R is the ratio of the reflected intensity IR to the incident intensity I0. Under 
these conditions a typical measurement at two incident angles (0.7 º and 3.0 º) was used to 
obtain the full reflectivity profiles. The phospholipid bilayers were formed in situ in the 
neutron reflectometer sample chamber after measuring the reference structure of the 
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underlying Si-SiO2 surface in D2O and H2O. Each lipid membrane structure was also 
measured in the same two contrasts before exposure to the proteins. Contrast changes were 
achieved by rinsing with 20 mL of the solvent. The slight variation in the SLD values of the 
bulk H2O and D2O are due to 90-100% efficiency of the solvent exchange process (the values 
are listed in the Supplementary material tables). Protein solutions (3 mL) in 10 mM Tris pH 
7.4 were injected over the lipid membranes at either 0.1 mg/mL, or stepwise at increasing 
concentrations (0.05, 0.25, 0.5 mg/mL), and changes in reflectivity were recorded at 10 min 
intervals at the first angle of incidence (0.7 °) for 30 min to observe any time-dependence 
before recording the final reflectivity profile at both angles in two contrasts. No change was 
observed between the 10 min measurements, and therefore the structure had already reached a 
time-independent state before the measurements were started. In experiment with the double 
cysteine mutant EqtII
V8C,K69C
, DTT at a final 2 mM concentration was injected after protein 
binding to release the disulphide bond between the α-helix and β-sandwich. 
 
 Details of the analysis of supported lipid membrane structure [58] and interaction with 
soluble proteins [59] using time-of-flight neutron reflection have been described in detail 
previously. Briefly, the neutron scattering length density profile (z) of a lipid bilayer can be 
described by distinct regions corresponding to the polar head groups and hydrophobic acyl 
chains due to their chemical differences. Reflectivity analysis is based on modelling the 
thickness, scattering length density, solvent volume fraction, and interfacial roughness of 
typically three layers corresponding to the lipid head groups and the acyl chain region. In 
membranes containing lipids, water and a protein, the scattering length density ρlayer is the 
sum of the molecular scattering length densities of the components ρi weighted by their 
volume fractions ϕ i: 
 
   ρlayer = ϕ lipidρlipid + ϕwaterρwater + ϕproteinρprotein 
 
Thus, when there are significant differences in the molecular scattering length densities of 
lipid, protein and water, their volume fractions can be computed from the fitted scattering 
length density profile of the membrane by using contrast variation. Varying the solvent D2O 
content allows the solvent volume fraction in the membrane to be determined. We 
additionally used lipids with deuterated (D-lipids) and non-deuterated (H-lipids) chains and 
proteins to detect the protein penetration independently from water penetration into the 
bilayers. 
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 Fig. 1 shows the different scattering contrasts used for lipid bilayers interacting with EqtII. 
For each membrane composition, the experiments were repeated up to eight times: H-lipids + 
H-EqtII, H-lipids + D-EqtII, D-lipids +H-EqtII and D-lipids + D-EqtII, each combination in 
pure H2O and pure D2O solvents respectively. The colouring in Fig. 1 illustrates the 
sensitivity of each contrast to different features of the structure. The Motofit program [60] 
was used for optical matrix modelling to calculate neutron reflectivity from these model 
structures, as described in the Supplementary Material. For each membrane, the fits to both 
solvent contrasts were refined in a simultaneous analysis until a global fit to the experimental 
data was found. Each parameter was fitted within limits chosen from a physically realistic 
parameter space considering the lipid molecular details (e.g. that the lipid chains could not be 
longer than the all-trans length of the chain). The fits were constrained by the requirement that 
the area per molecule derived from the fitted thickness and volume fraction had to be constant 
for the lipid head groups and chains to within the fitting errors. For the several individual 
samples formed to obtain all measured contrasts, the data were fitted to global trends in the 
type of structure formed, while relaxing the absolute requirement on a global structure. The 
values listed in the tables of results are the average values from all sample formed. The 
individual sample structures are listed in the Supplementary material. 
 
 The scattering length densities of the phospholipids were calculated from volume fractions 
of the lipid components obtained from molecular dynamics simulations benchmarked against 
experimental data [61] and for the proteins they were calculated from the sequences and 
amino acid volumes determined in solution [62], assuming that protons on polar residues are 
exchangeable with the solvent, giving both deuterated and non-deuterated EqtII a different 
scattering length density in H2O and D2O solvents. Considering the limited experimental 
resolution to the thickness and volume fraction of protein layers with a high solvent content, 
as is the case for EqtII, a uniform scattering length density was used to describe the protein 
instead of a detailed profile derived by projections of the crystal structure in different 
orientations [48]. The penetration and volume fraction of EqtII (% EqtII) in the lipid bilayer 
were derived from the changes to the fitted lipid scattering length density compared to the 
values for the pure lipid. The values used for the lipids and proteins are listed in Table S1 
(Supplementary material). The errors in the structural parameters were derived from the 
maximum acceptable variation in each fitted parameter (thickness, scattering length density 
and lipid volume fraction) that allowed a fit to all contrasts to be maintained, as described in 
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more detail in the Supplementary material. The errors in independent parameters of the model 
sublayers are coupled in such a way that the overall errors in membrane lipid volume fraction 
and thickness are ±10% and ±2 Å, respectively. The uncertainty in the penetration depth of 
the protein corresponds to the uncertainty in fitting the thickness of the lipid headgroups 
and/or lipid chain layers. A more detailed penetration model was not considered, as the small 
amounts of protein do not allow the penetration depth to be resolved in greater detail. 
 
3. Results 
 To determine protein location and possible pore formation, the interactions of both wild-
type EqtII and EqtII
V8C,K69C
 with three different types of membranes were characterised using 
several isotopic contrasts with deuterated (D-EqtII) and non-deuterated (H-EqtII) versions of 
both proteins, and deuterated (D-lipids) and non-deuterated (H-lipids) DMPC in two different 
solvent contrasts (H2O and D2O), as shown in Fig. 1. The EqtII concentrations in solution 
were 0.1 mg/mL (5.0 μM) unless otherwise stated. The full model structures fitted to all lipid 
bilayers are described in the Supplementary material. 
 
3.1. Structure of lipid bilayers 
 Lipid bilayers were prepared from pure DMPC, DMPC containing sphingomyelin (SM) 
and DMPC containing both SM and Chol. The main structural parameters, averaged over all 
bilayers prepared, measured before the introduction of EqtII are shown in Table 1. The lipid 
volume fraction in the bilayers prepared varied between 0.92 and 0.96, showing that the 
formation from sonicated vesicles is very reproducible. 
 
 DMPC bilayers at 30 °C have a total thickness of 41±2 Å, with an average area per 
molecule of 62±5 Å
2
, and a polar head group thickness of 7±1 Å. The 20 mol% and 30 mol% 
SM-containing bilayers are 44±2 Å thick, with the head group conformation extended to 8±1 
Å with an increased solvent volume fraction of 34±3 v/v% compared to 19±3 v/v% in pure 
DMPC. There is a small difference in the headgroup conformation in the 20 mol% SM 
bilayer, with a slightly higher solvent fraction (40±10 v/v%) and thickness (9±1 Å) on the 
surface-proximal side compared to the headgroups facing the solution. Such a difference is 
often observed due to the additional water incorporated between the bilayer and the substrate 
due to the roughness of the silica surface (4-6 Å). The actual SM contents, as determined by 
fitting the neutron scattering length density of the lipid chains in D54DMPC membranes, were 
22±3 and 27±3 mol% for the nominal 20 and 30 mol% samples. 
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 The presence of Chol increases the membrane thickness to 47±2 Å, with the lipid chain 
area per molecule decreasing to 57±4 Å
2
. The scattering length density of the D54-DMPC 
membrane with 20 mol% SM and 10 mol% Chol can be fitted to 3.8 x 10
-6
 Å
-2
. 
 
3.2. Binding of EqtII to DMPC Membranes 
 Wild-type EqtII binds very weakly to pure DMPC bilayers, as shown in Fig. 2a, in which 
the normalised neutron reflectivity profiles of the membranes before and after toxin injection 
show only modest changes. The structural parameters fitted to DMPC bilayers after EqtII 
interaction are summarized in Table 2. The structure of the hydrophobic membrane core is not 
altered by EqtII, which binds at the head group-water interface at 0.13±0.03 μmol m-2. From 
the changes in the scattering length density model shown in Fig. 2b we can infer that the toxin 
penetrates into the phosphatidylcholine head groups, which have a thickness of 7±1 Å, and 
extends 15±3 Å above the surface of the membrane. The lipid head group scattering length 
density (1.8 x 10
-6
 Å
-2
 for a DMPC head group) increases to 2.5 x 10
-6
 Å
-2
 upon interaction 
with D-EqtII and to 2.0 x 10
-6
 Å
-2 
with H-EqtII, which corresponds to 12.5±6% of the lipid 
head group volume being occupied by the protein. The dimensions of a single EqtII molecule 
have been reported to be 42 Å x 28 Å x 32 Å in the crystal structure [29]. Considering the low 
surface density of EqtII at the membrane surface, a layer with a homogeneous scattering 
length density was used to model the protein, instead of direct projections from the crystal 
structure [63]. As no specific deuterium label was attached to the N-terminal α-helix, it is not 
possible to say directly what its orientation relative to the membrane surface is, but the total 
protein layer thickness of 22±4 Å corresponds well to the shortest protein axis and indicates 
that only a single protein layer is partially embedded in the membrane, with a relatively 
parallel orientation of the protein long axis to the membrane surface. No change is observed 
in the lipid chain region that would indicate EqtII penetration or pore formation, to within the 
precision with which these can be determined from the fits (±3 v/v%), as demonstrated in 
Figures 2c and 2d. A similar procedure was applied to each fitting parameter to determine the 
uncertainties listed in Tables 1-5. 
 
3.3. Binding of EqtII to SM-containing membranes 
 The structural parameters for EqtII in membranes containing 20 mol% and 30 mol% SM 
are summarized in Table 2, with the reflectivity data and scattering length density profiles 
shown in Fig. 3. The presence of SM significantly strengthens the EqtII-membrane 
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interaction, as evidenced by the higher surface coverage of protein (0.23±0.027 and 
0.42±0.072 μmol m-2 for 20 and 30 mol% SM, respectively). Although a small change in the 
total scattering length density of the lipid chain region is observed, it can be attributed to the 
uncertainty in determining the solvent present in the tails (±0.05 v/v%); alternatively, the 
expulsion of a small amount of solvent when the protein binding to the lipid head groups 
leads to an area expansion of the lipids. There is no indication that EqtII penetrates into the 
hydrophobic lipid core or changes the overall membrane structure. EqtII interacts with the 
lipid head groups in a manner similar to that in pure DMPC in terms of the penetration depth 
(7±1 Å), but the thickness of the EqtII layer outside the membrane surface is on average 31±3 
Å, twice the thickness on pure DMPC membranes, which, considering the ± 3 Å experimental 
error in determining the protein layer thickness, is a clear indication that the average 
orientation of the toxin is different. This reorientation at the membrane surface could be as a 
result of a different mode of binding through the SM-binding site. The residues involved in 
the SM interaction are located at the end of the longest axis of the protein [24, 25, 64], which 
would place the β-sandwich in a more upright orientation perpendicular to the membrane 
surface, consistent with the total protein layer thickness being 39±3 Å. 
 
 The volume fractions of EqtII in the lipid head groups and on the membrane surface are 
somewhat higher compared to pure DMPC. There is no difference in the protein layer 
thickness between 20 and 30 mol% SM, but both the amount of protein (0.42±0.0072 μmol m-
2
) and the fraction of EqtII that penetrates into the lipid head groups is higher (37% relative to 
the lipid head group volume) for 30 mol% SM. The fraction of EqtII penetrating into the lipid 
head groups is comparable to the estimated volume of the α-helix relative to the rest of the 
protein based on NMR [28] (7%), synchrotron circular dichroism [65] (9±4%) or X-ray 
crystallography [29] (12%) studies. However, based on these data alone, we cannot infer that 
it is the helix that is embedded in the head groups and not another part of the protein.. 
 
3.4. Binding of EqtII to membranes containing SM and Chol  
 The interaction of EqtII was investigated with membranes containing 10 mol% Chol and 
20 or 30 mol% SM, and as function of EqtII concentration. The structural parameters are 
summarised in Table 2, with the scattering length density profiles and corresponding model 
structures shown in Fig. 4. 
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 The thickness and protein volume fraction of the EqtII layer on the surface of the lipid 
membrane are both similar to the membranes containing only DMPC and SM, but D-EqtII 
increases the chain scattering length density of the H-lipids from -0.3 x 10
-6 
Å
-2
 to +0.12 x 10
-
6 
Å
-2
 in H2O and to +0.59 x 10
-6 
Å
-2
 in D2O for 20 mol% SM and 10 mol% cholesterol. In the 
D-lipid bilayer, H-EqtII changes the chain scattering length density from 3.8 x 10
-6 
Å
-2
 to 3.77 
x 10
-6 
Å
-2
 in H2O and 3.66 x 10
-6 
Å
-2
 in D2O (see Supplementary material Table S4 for full 
details). The presence of Chol gives rise to penetration of EqtII across the hydrophobic lipid 
core, where the protein extends through to the opposing lipid head groups. However, there is 
no solvent penetration observed at either SM concentration, indicating that no open pores are 
formed. At 0.1 mg/mL EqtII, the protein volume fraction found in the lipid core is relatively 
low (10±2 %), and in the head groups it is similar to that found with SM only (11±3 %). 
Increasing the EqtII concentration to 0.5 mg/mL doubles the amount of protein outside the 
membrane surface, but leads to no further penetration into either the lipid head groups or lipid 
chains. Increasing the SM concentration to 30 mol% has only a moderate effect. The total 
protein amount bound to the membrane surface increases from 0.3 to 0.34 μmol m-2, and the 
volume fraction of the protein volume penetrating into the lipid chains (15±5 %) and head 
groups (20±5 %) increases significantly more in the head groups. This implies that either the 
helix is not fully inserted, or that only some EqtII molecules at the membrane surface are able 
to penetrate into the lipid core.  
 
 When the membrane-EqtII assembly is cooled to 18 °C, which is below the liquid 
crystalline phase transition of both DMPC (24 °C) [66] and egg-SM (35-44 °C) [67], crossing 
the phase boundary into the gel-phase, the reflectivity profile changes substantially, 
corresponding to thickening of the membrane by 4±1 Å and significant water penetration (22 
v/v% relative to the lipids) across the membrane, indicating that pore formation is enabled. 
Concurrently the protein layer outside the membrane shrinks from 35±3 Å to 16±3 Å in 
thickness, suggesting that in the pore, the orientation of the β-sandwich relative to the 
membrane changes to more parallel compared to the non-pore state. 
 
 The amount of EqtII bound to the surface of the membrane and penetrating into 10 mol% 
Chol and 20 mol% SM-containing membranes was determined as a function of EqtII 
concentration (Fig. 5a,b). The data suggest that the EqtII binding is already close to being 
saturated at 0.05 mg/ml as the changes that occur at higher concentrations mainly correspond 
to an increasing number of EqtII molecules penetrating the membrane, while it is difficult to 
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determine small changes in the protein layer outside the membrane as it contains only 5±3 
v/v% protein. As can be seen from the changes in membrane structure in Table 4, EqtII 
penetrates into the lipid core already at 0.05 mg/mL concentration, and the amount of protein 
increases with EqtII concentration in solution, but even at 0.5 mg/mL EqtII in solution, no 
water penetration suggesting open pore formation is observed. This is consistent with the fact 
that, at the lipid compositions studied, the membranes do not form phase-separated domains, 
which have been shown to occur only at relatively high Chol (36 mol%) and SM (50 mol%) 
fractions with DMPC [68], as opposed to more unsaturated lipids such as POPC [69]. The 
main effect of increasing concentration is to increase the volume fraction of protein 
penetrating into both the lipid head groups and chains while both the penetration depth and 
the volume fraction of protein outside the membrane stay constant. 
 
3.5. Binding of EqtII
V8C,K69C
 to membranes 
 To elucidate the role of the N-terminal α-helix in membrane binding of EqtII, we also 
investigated the binding of the double cysteine mutant EqtII
V8C,K69C
O to DMPC, DMPC-SM 
and DMPC-SM-Chol membranes. The results are summarized in Table 5, with the changes in 
reflectivity and scattering length density profiles shown in Fig. 6. The scattering length 
density profiles in Fig 6 are convoluted with the surface roughness, which was in this case 
higher than in the other samples (8-16 Å), and as a consequence the SLD profiles do not 
describe only the lipid bilayer structure, for which the fitted structures can be found in the 
Supplementary material Tables S8-S10. The oxidized, inactive mutant binds to all membranes 
with a similar affinity to the wild-type protein, but with two key differences. The mutant 
protein layer outside the membrane surface is considerably thicker than for the wild-type 
protein on pure DMPC membranes, with the EqtII
 V8C,K69C
O layer extending to 30±3 Å above 
the membrane, indicating that the mutant binds in a different orientation. In the presence of 
SM or both SM and Chol the mutant protein layer thickness outside the membrane is similar 
to that of wild-type EqtII, but binding of the mutant is partially reversible, with up to 50 % of 
the protein being washed off by a buffer rinse in all experiments. Such reversibility was not 
observed for the wild-type protein. Most importantly, the mutant only interacts with the lipid 
head groups in all cases, with no protein penetration into the lipid core. The small changes in 
lipid chain SLD listed in the Supplementary material tables are within the fitting uncertainty  
(± 0.05 x 10
-6
 Å
-2
). 
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 When the α-helix is released in situ by the addition of 2 mM DTT, further changes in 
reflectivity are observed. In pure DMPC membranes, the addition of DTT only causes 
desorption of the protein, consistent with reversible binding of the wild-type protein with pure 
DMPC. In SM-containing membranes the mutant protein layer outside the membrane surface 
primarily becomes thinner upon DTT addition, with approximately 30 % of the protein 
removed, suggesting that the protein is partially reversibly bound. However, in the presence 
of Chol an irreversible penetration into the lipid chains is observed, with the amount of EqtII 
extending across the membrane being essentially identical to the wild-type protein, to within 
experimental error. This very strongly supports the role of α-helix dissociation as a pre-
requisite for membrane insertion and ultimately pore formation. 
 
 In SM- and Chol-containing membranes, the inactive, oxidized EqtII
V8C,K69C
O mutant 
shows more of a concentration dependence than the wild-type protein, as documented in 
Table 4. At 0.05 mg/mL, the amount of EqtII
V8C,K69C
O adsorbed on the membrane is low, and 
the layer thickness is only 20±3 Å. At this concentration, no EqtII
V8C,K69C
O can be detected 
penetrating into the lipid head groups, but at higher concentrations the amount in the head 
groups increases in proportion to the total amount of protein, which also displaces solvent 
from the headgroups. This leads to an apparent shift in the lipid headgroup position in the 
scattering length density profile in Figure 5d, which, however, corresponds only to the 
changes in scattering length density/solvent penetration in this region. Above 0.1 mg/mL, the 
thickness of the EqtII
V8C,K69C
O layer is constant at 45±4 Å, and, although the amount of 
protein increases with concentration, at each step up to 50 % of the protein was removed upon 
changing to a pure buffer solution, indicating partially reversible binding. 
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4. Discussion 
 Our neutron reflection results reveal several new details about the membrane binding 
process of EqtII as a result of the sensitivity of the method to the location, dimensions and 
amount of protein at the membrane interface, as well as the ability to observe structural 
changes taking place in the lipid matrix (Fig. 7). The phospholipid DMPC was chosen to 
allow us to observe the initial stages of EqtII binding and penetration, as the toxin has lower 
binding and permeabilising activity towards DMPC membranes than corresponding 
membranes formed with unsaturated phospholipids, such as DOPC [65]. We also verified this 
by measuring the residual haemolytic activity of unbound EqtII after mixing it with lipid 
vesicles of different lipid composition. It is clear that vesicles composed of DMPC and its 
various mixtures with SM and Chol do not promote efficient membrane binding to the extent 
observed with vesicles that contain the unsaturated lipid DOPC (Fig. S3, Supplementary 
material). 
 
 The perturbation by EqtII of model lipid membranes composed of PC and SM has 
previously been investigated using solid-state NMR and electron microscopy [70, 71], which 
showed that the toxin enhanced slow motions in the membrane lipids and destabilized 
membranes containing SM, suggesting a preferential interaction between the toxin and SM. 
High-resolution 
19
F NMR studies [72] shed further light on the interaction, with binding to PC 
micelles and bicelles causing significant perturbation of resonances from Trp112 and 116 and 
to a lesser extent Trp117. Subsequent interaction with SM caused further distinct changes, but 
the interaction with SM was not sufficient to trigger dissociation of the N-terminal helix from 
the β-sandwich [72]. 
 
 Our results indicate that EqtII binds peripherally and weakly to pure DMPC. SM promotes 
the binding of EqtII and induces a change in the protein orientation on the membrane surface; 
the extension of the toxin outside the lipid surface doubles upon introducing 20 mol% SM. 
This corresponds more closely to the model of SM-bound EqtII, and actinoporins in general, 
where the protein interacts with SM through aromatic amino acid residues Trp112 and Tyr113 
located in loop at the end of the long axis of the molecule and on the C-terminal α-helix [64]. 
Such an interaction should reorient the protein in a more vertical orientation, with its long axis 
approximately perpendicular to the plane of the membrane. This also correlates well with the 
distinct effect of SM observed on the key Trp residues by 
19
F NMR [72]. The fraction of EqtII 
penetrating into the lipid head groups is modest both with and without SM, corresponding to a 
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significantly smaller part of the protein than the predicted α-helical content, from which we 
can infer that, in the absence of Chol, α-helix dissociation has not occurred on these 
membranes. 
 
 A modest amount of Chol (10 mol%) gives rise to EqtII penetration all the way across the 
outer lipid head groups and the membrane hydrophobic core, which has a thickness of 30±1 
Å. The helix is proposed to consist of 30 residues once in a membrane, which is long enough 
to span the membrane. The orientation of the protein remaining outside the membrane 
remains similar to that in the presence of SM alone. No water is observed to penetrate the 
membrane to within the experimental detection limit (±3 v/v% relative to the lipids), 
indicating that no open pores are formed, and the addition of further SM only promotes the 
binding and penetration of more EqtII, but still without water penetration. This type of initial 
penetration has been proposed recently to be an intermediate step in the EqtII pore formation 
process, preceding the oligomerization of several EqtII helices into an open pore within the 
membrane [39]. 
 
 Although SM in PC membranes alone has been observed to lead to EqtII insertion and pore 
formation [73], and EqtII also exhibits some activity in Chol-PC mixtures, the permeabilizing 
activity strongly depends on the proportions of each lipid in a way that can be related to the 
phase coexistence regions in the lipid mixtures. In our case, the phase diagram of DMPC, SM 
and Chol has a relatively small phase coexistence region at much higher SM and Chol 
fractions than those used in this study [68]. The membrane compositions in our study 
correspond to a uniform phase, which is fluid at 30 °C and in the gel phase at 18 °C. 
However, a transition between these two temperatures involves the formation of domains. The 
observation that cooling the DMPC-SM-Chol-EqtII assembly to 18 °C in situ induced a 
significant amount of water penetration across the membranes supports the proposed role for 
lipid phase separation in actinoporin pore formation [74, 75], and the affinity of EqtII for lipid 
microdomains in the plasma membrane [76]. 
 
 We have shown that EqtII has several different modes of binding to lipid membranes prior 
to pore formation, suggesting that the orientation of the protein before insertion is different in 
pure PC membranes compared to SM- or SM- and Chol-containing systems. The existence of 
a non-pore form of EqtII that spans the lipid membrane is consistent with the proposed 
mechanism of pore formation, and is also interesting from the point of view of having a less 
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toxic form of the protein for SM-imaging applications in live cells using GFP [77]. The 
double cysteine mutant of EqtII binds to all membranes with a similar affinity to the wild-type 
protein, but shows no penetration into the lipid chains. Releasing the α-helix in situ by DTT in 
the presence of Chol causes full penetration of the protein across the lipid core in a manner 
which is essentially identical to the wild-type protein. This strongly supports the key role of 
helix dissociation in pore formation. 
 
5. Conclusions 
 By using neutron reflection, we have elucidated the structures of membranes interacting 
with the actinoporin EqtII. We have shown that EqtII binds in several distinct orientations 
depending on membrane lipid composition, which has not been observed previously. We also 
show that Chol is required for the penetration of the α-helix across the lipid bilayer, which 
occurs prior to pore formation at relatively low SM and Chol contents. We show that an 
intermediate state of EqtII inserts deeply into membranes without pore formation, which is 
dependent on lipid phase separation, and suggests that membrane domains play a role in the 
mechanism of EqtII pore formation. Through the use of a double cysteine mutant, we have 
directly confirmed the role of α-helix dissociation as a pre-requisite for membrane 
penetration. Our results demonstrate the effectiveness of in situ structure determination using 
neutron reflection and form the basis for more detailed studies of the effects of lipid 
composition on actinoporin interactions and pore formation in membranes. 
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Tables 
 
 
Table 1 
Structure of supported lipid bilayers before interaction with EqtII* 
 DMPC 20% SM
 
30% SM 20%SM 10% Chol 30% SM 10% Chol 
Membrane 
thickness (Å) 
41±2 44±2 44±2 47±2 46±2 
Lipid area per 
molecule (Å
2
) 
61.5±6 61±6 61±6 57.5±5 54.5±5 
% solvent in 
head groups 
18.5±10 36.5±10 33±10 35±10 28±10 
% solvent in 
chains 
6±5 0±5 6±5 4±5 1±5 
* these values are the average of all prepared bilayers, for which the full data can be found in 
the Supplementary material. 
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Table 2  
Structure of supported lipid bilayers after introduction of EqtII* 
 DMPC 20% SM
# 
30% SM 20% SM  
10% Chol 
30% SM  
10% Chol 
Membrane 
thickness (Å) 
39±2 41±2 42±2 47±2 46±2 
Lipid area per 
molecule (Å
2
) 
61±6 63±5 60±5 54±5 53±5 
% solvent in 
head groups 
19.5±10 38±10
i
 
25±10
o
 
32±10
i
 
28±10
o
 
35±10
i
 
40±10
o
 
22±10 
% solvent in 
chains 
2±5 0±5 0±5 2.5±5 0±5 
EqtII μMol m-2 0.13 
±0.03 
0.23 ±0.03 0.42 
±0.07 
0.30±0.09 
 
0.34±0.10 
EqtII layer (Å) 15±3 31±3 27±3 33±3 30±3 
v/v% Eqt
$
 6±3 10±5 16±5 10±5 13±5 
EqtII depth (Å) 7±3 8±3 8±3 39±3 38±3 
v/v% Eqt in 
lipid heads
¶
 
12.5±3 15±3 37±6 10±3 20±3 
v/v% Eqt  in 
lipid chains
¶
 
- - - 11±3 17±3 
* these values are the average of  all prepared bilayers 
#
Values from experiments with D54-DMPC only when no multilayer formation was observed 
i
 inner head groups facing the silicon oxide 
o
 outer head groups facing the solution 
$ 
Volume fraction of protein relative to water 
¶ 
Volume fraction of protein relative to lipids 
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Table 3  
Membrane structure upon addition of 0.5 mg/mL EqtII at 30 °C and after cooling the 
membrane-EqtII assembly to 18 °C. 
20% SM 
10% Chol  
0.5mg/mL 
30°C 
0.5mg/mL 
18°C 
Membrane 
thickness (Å) 
47±2 51±2 
Lipid area per 
molecule (Å
2
) 
55±5* 61±6* 
% solvent in 
head groups 
30±10 
 
19±10 i 
14±10 o 
 % solvent in 
chains 
5±5 22±5 
EqtII μMol m-2 0.067±0.016 0.049±0.017 
EqtII layer (Å) 35±3 16±3 
v/v% Eqt 24±5 39±5 
EqtII depth (Å) 38±3 43±3 
v/v% Eqt in 
lipid heads 
13±5 38±5 
v/v% Eqt  in 
lipid chains 
25±2 25±5 
*wet area per lipid including the area occupied the solvent. 
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Table 4  
Effect of EqtII-WT and EqtII
V8C,K69C
O concentration on binding to DMPC-20 mol% SM-10 
mol% Chol bilayers. 
 EqtII-WT EqtII
V8C,K69C
 
EqtII mg/mL 0.05 0.25
 
0.5 0.05 0.25 0.5 
Membrane 
thickness (Å) 
49.5±2 49±2 50±2 48±2 54±2 50±2 
Lipid area per 
molecule 
(Å
2
) 
55±5 55±5 53±5 57.5±5 55.5±5 55.5±5 
% solvent in 
head groups 
35±10 35±10 35±10 32±10 i 
29±10 o 
32±10 
 
38.5±10 i 
28±10 o 
% solvent in 
lipid chains 
4±5
#
 4±5 4±5 5±5 1.5±5 0±5 
EqtII 
thickness (Å) 
71±4 71±4 71±4 20±3 47±3 45±3 
EqtII 
penetration 
depth/Å
§ 
41±4 41±4 41±4 0±3 12±3 10±3 
v/v% EqtII 
outside 
membrane
$
 
7±3 4±3 5±3 6±3 6±3 12.5±3 
v/v% EqtII in 
lipid head 
groups
¶
 
8±6 12.5±6 10±6 - 43±6 43±6 
v/v % EqtII 
in lipid 
chains
¶
 
8.5±3 10.5±3 17±3 - - - 
# 
the lipid bilayers had a chain solvent fraction of 4±5 before introduction of the proteins 
*
 measured with protein solution in contact with membrane
/**
 after exchanging to pure buffer 
§
 The total thickness of the lipid head group and chain regions in which an SLD change was 
observed 
$ 
Volume fraction of protein relative to water 
¶ 
Volume fraction of protein relative to lipids 
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Table 5 
Binding of EqtII
V8C,K69C
O
 
to DMPC, DMPC-20 mol% SM and DMPC-20 mol% SM-10 
mol% Chol membranes before and after conversion into EqtII
V8C,K69C
R by 2 mM DTT. 
 DMPC DMPC 
+ DTT 
20% SM
 
20% SM+ 
DTT 
20%SM  
10% Chol 
20%SM  
10% Chol+  
DTT 
Membrane 
thickness /Å 
40±2  43±2 43±2 44±2 44±2 
Lipid area per 
molecule /Å 
61±5  63±6 63±6 58±5 58±5 
% solvent in 
head groups 
25±10  35±10 i 
25±10 o 
35±10 i 
25±10 o 
32±10 i 
25±10 o 
35±10 i 
22±10 o 
% solvent in 
chains 
0±5  10±5 10±5 0±5 0±5 
EqtII μMol m-2 0.02±0.01  0.03±0.01 0.02±0.01 0.05±0.01 
 
0.05±0.01 
EqtII 
thickness/Å 
30±3  38±3 31±3 48±3 71±3 
v/v% Eqt 
outside
$
 
membrane 
7±3  14±5 10±5 20±5 15±5 
EqtII 
penetration 
depth/Å
§ 
-  8±3 8±3 8±3 36±3 
v/v% Eqt in 
lipid head 
groups
¶
 
-  12.5 12.5 11±3 33±3 
v/v % Eqt in 
lipids chains
¶
 
 
- 
 
- 
 
- 
 
- 
 
- 
 
7.5±3 
i head groups facing towards silica support 
o head groups facing towards solution 
$ 
Volume fraction of protein relative to water 
§
 The total thickness of the lipid head group and chain regions in which an SLD change was 
observed 
¶ 
Volume fraction of protein relative to lipids 
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Legends to figures 
 
Fig. 1. Schematic representation of the structural model and contrasts used to fit data from 
lipid bilayers before and after interaction with EqtII. 
Red represents deuterium labelling and blue unlabelled material. 
 
Fig. 2. Interaction of EqtII with DMPC and D54-DMPC membranes 
a) Neutron reflectivity profiles of DMPC and D54-DMPC membranes before and after EqtII 
injection at 0.1 mg/mL in H2O and D2O, represented as the Fresnel reflectivity RQ
4
. The solid 
lines show the best fit to the data corresponding to the scattering length density (SLD) profiles 
in b), which also shows a schematic illustration of the EqtII location and possible orientations 
at the membrane-water interface. Sensitivity of the fit to c) the presence of solvent in the lipid 
bilayer – the black solid line shows a change of 3v/v% D2O in the lipid chains - and d) the 
penetration of EqtII into the lipid hydrocarbon chains – the solid black line shows a change in 
the lipid chain scattering length density by the -0.1 x 10
-6 
Å
-2 
corresponding to the penetration 
of 3 v/v% of H-Eqt in the deuterated lipid chains. 
 
Fig. 3. Interaction of EqtII with DMPC and D54-DMPC membranes containing SM 
Neutron reflectivity profiles of D54-DMPC membranes with a) 20 mol% and c) 30 mol% SM 
before and after EqtII injection at 0.1 mg/mL in H2O and D2O. The solid lines show the best 
fit to the data corresponding to the scattering length density (SLD) profiles in b) and d), which 
also indicate the EqtII location and possible orientations at the membrane-water interface. 
 
Fig. 4. Interaction of EqtII with DMPC and D54-DMPC membranes containing SM and Chol 
Reflectivity profiles and scattering length density profiles and model structures (Table 3) of 
D54-DMPC membranes with 10 mol% Chol and a,b) 20 mol% or c,d) 30 mol% SM before 
and after EqtII injection at 0.1 mg/mL in H2O and D2O. b,d) Illustration of EqtII location and 
possible orientations of the embedded α-helix. The green EqtII cartoons in b) illustrate the 
membrane thickening and aqueous pore formation that occurs upon cooling the membrane-
EqtII assembly to 18 °C, crossing the gel-phase boundary. 
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Fig. 5. Association of EqtII and EqtII
V8C,K69C
O at different protein concentration 
Reflectivity profiles (plotted as normalised reflectivity RQ
4
 to emphasize differences in the 
membrane reflectivity) and neutron scattering length density profiles illustrating the model 
structures (4) fitted for DMPC-20 mol% SM 10%Chol as function of a,b) H-Eqt-WT 
concentration and c,d) EqtII
V8C,K69C
O concentration in H2O and D2O. 
 
Fig. 6. Interaction of D-EqtII
V8C,K69C
O with membranes 
Reflectivity profiles and neutron scattering length density profiles of a,b) DMPC, c,d) DMPC-
20 mol% SM and e,f) DMPC-20mol% SM-10 mol% Chol membranes before and after 
EqtII
V8C,K69C
O injection at 0.1 mg/mL in H2O and D2O. f) illustrates the penetration of the 
protein that occurs upon addition of 2 mM DTT in the presence of Chol. 
 
Fig. 7. Schematic summary of the binding of EqtII-WT and EqtII
V8C,K69C
O to lipid bilayers. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 26 
Acknowledgements 
The authors thank the Institut Laue-Langevin for the experimental neutron beam time, the 
provision of deuterated protein, a as well as use of the supporting facilities of the Partnership 
for Soft Condensed Matter. V.T.F. and M.H. acknowledge support from the UK EPSRC 
under grants GR/R99393/01 and EP/C015452/1 for the development of the Deuteration 
Laboratory at the ILL. This work was supported in part by the Access to Major Research 
Facilities Program administered by ANSTO and the Slovenian Research Agency. R.S.N. 
acknowledges fellowship support from the Australian National Health and Medical Research 
Council. 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 27 
References 
[1] G. Anderluh, P. Maček, Cytolytic peptide and protein toxins from sea anemones 
(Anthozoa: Actiniaria), Toxicon, 40 (2002) 111-124. 
[2] K. Črnigoj Kristan, G. Viero, M. Dalla Serra, P. Maček, G. Anderluh, Molecular 
mechanism of pore formation by actinoporins, Toxicon, 54 (2009) 1125-1134. 
[3] L. Garcia-Ortega, J. Alegre-Cebollada, S. Garcia-Linares, M. Bruix, A. Martinez-Del-
Pozo, J.G. Gavilanes, The behavior of sea anemone actinoporins at the water-membrane 
interface, Biochim. Biophys. Acta, 1808 (2011) 2275-2288. 
[4] G. Anderluh, J.H. Lakey, Disparate proteins use similar architectures to damage 
membranes, Trends Biochem. Sci., 33 (2008) 482-490. 
[5] R.J. Gilbert, M. Dalla Serra, C.J. Froelich, M.I. Wallace, G. Anderluh, Membrane pore 
formation at protein-lipid interfaces, Trends Biochem. Sci., 39 (2014) 510-516. 
[6] G. Belmonte, C. Pederzolli, P. Maček, G. Menestrina, Pore formation by the sea anemone 
cytolysin equinatoxin II in red blood cells and model lipid membranes, J. Membr. Biol., 131 
(1993) 11-22. 
[7] V. de los Rios, J.M. Mancheno, A. Martinez del Pozo, C. Alfonso, G. Rivas, M. Onaderra, 
J.G. Gavilanes, Sticholysin II, a cytolysin from the sea anemone Stichodactyla helianthus, is a 
monomer-tetramer associating protein, FEBS Lett., 455 (1999) 27-30. 
[8] G. Anderluh, A. Barlič, C. Potrich, P. Maček, G. Menestrina, Lysine 77 is a key residue in 
aggregation of equinatoxin II, a pore-forming toxin from sea anemone Actinia equina, J. 
Membr. Biol., 173 (2000) 47-55. 
[9] M. Tejuca, M. Dalla Serra, C. Potrich, C. Alvarez, G. Menestrina, Sizing the radius of the 
pore formed in erythrocytes and lipid vesicles by the toxin sticholysin I from the sea anemone 
Stichodactyla helianthus, J. Membr. Biol., 183 (2001) 125-135. 
[10] M. Tejuca, M. Dalla Serra, M. Ferreras, M.E. Lanio, G. Menestrina, Mechanism of 
membrane permeabilization by sticholysin I, a cytolysin isolated from the venom of the sea 
anemone Stichodactyla helianthus, Biochemistry, 35 (1996) 14947-14957. 
[11] M.A. Baker, N. Rojko, B. Cronin, G. Anderluh, M.I. Wallace, Photobleaching reveals 
heterogeneous stoichiometry for equinatoxin II oligomers, Chembiochem, 15 (2014) 2139-
2145. 
[12] Y. Subburaj, U. Ros, E. Hermann, R. Tong, A.J. Garcia-Saez, Toxicity of an α-pore-
forming toxin depends on the assembly mechanism on the target membrane as revealed by 
single-molecule imaging, J. Biol. Chem., 290 (2015) 4856-4865. 
[13] J.M. Mancheno, J. Martin-Benito, M. Martinez-Ripoll, J.G. Gavilanes, J.A. Hermoso, 
Crystal and electron microscopy structures of sticholysin II actinoporin reveal insights into 
the mechanism of membrane pore formation, Structure, 11 (2003) 1319-1328. 
[14] A.E. Mechaly, A. Bellomio, D. Gil-Carton, K. Morante, M. Valle, J.M. Gonzalez-Manas, 
D.M. Guerin, Structural insights into the oligomerization and architecture of eukaryotic 
membrane pore-forming toxins, Structure, 19 (2011) 181-191. 
[15] K. Tanaka, J.M. Caaveiro, K. Morante, J.M. Gonzalez-Manas, K. Tsumoto, Structural 
basis for self-assembly of a cytolytic pore lined by protein and lipid, Nature Comm., 6 (2015) 
6337. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 28 
[16] A.W. Bernheimer, L.S. Avigad, Properties of a toxin from the sea anemone Stoichacis 
helianthus, including specific binding to sphingomyelin, Proc. Natl. Acad. Sci. U. S. A, 73 
(1976) 467-471. 
[17] R. Linder, A.W. Bernheimer, K.S. Kim, Interaction between sphingomyelin and a 
cytolysin from the sea anemone Stoichactis helianthus, Biochim. Biophys. Acta, 467 (1977) 
290-300. 
[18] V. de los Rios, J.M. Mancheno, M.E. Lanio, M. Onaderra, J.G. Gavilanes, Mechanism of 
the leakage induced on lipid model membranes by the hemolytic protein sticholysin II from 
the sea anemone Stichodactyla helianthus, Eur. J. Biochem., 252 (1998) 284-289. 
[19] R.J. Simpson, G.E. Reid, R.L. Moritz, C. Morton, R.S. Norton, Complete amino acid 
sequence of tenebrosin-C, a cardiac stimulatory and haemolytic protein from the sea anemone 
Actinia tenebrosa, Eur. J. Biochem., 190 (1990) 319-328. 
[20] R.S. Norton, G. Bobek, J.O. Ivanov, M. Thomson, E. Fiala-Beer, R.L. Moritz, R.J. 
Simpson, Purification and characterisation of proteins with cardiac stimulatory and 
haemolytic activity from the anemone Actinia tenebrosa, Toxicon, 28 (1990) 29-41. 
[21] R.S. Norton, P. Maček, G.E. Reid, R.J. Simpson, Relationship between the cytolysins 
tenebrosin-C from Actinia tenebrosa and equinatoxin II from Actinia equina, Toxicon, 30 
(1992) 13-23. 
[22] P. Galettis, R.S. Norton, Biochemical and pharmacological studies of the mechanism of 
action of tenebrosin-C, a cardiac stimulatory and haemolytic protein from the sea anemone, 
Actinia tenebrosa, Toxicon, 28 (1990) 695-706. 
[23] P. Maček, D. Lebez, Isolation and characterization of three lethal and hemolytic toxins 
from the sea anemone Actinia equina L, Toxicon, 26 (1988) 441-451. 
[24] B. Bakrač, G. Anderluh, Molecular mechanism of sphingomyelin-specific membrane 
binding and pore formation by actinoporins, Adv. Exp. Med. Biol., 677 (2010) 106-115. 
[25] T. Maula, Y.J. Isaksson, S. Garcia-Linares, S. Niinivehmas, O.T. Pentikainen, M. Kurita, 
S. Yamaguchi, T. Yamamoto, S. Katsumura, J.G. Gavilanes, A. Martinez-del-Pozo, J.P. 
Slotte, 2NH and 3OH are crucial structural requirements in sphingomyelin for sticholysin II 
binding and pore formation in bilayer membranes, Biochim. Biophys. Acta, 1828 (2013) 
1390-1395. 
[26] G. Belmonte, G. Menestrina, C. Pederzolli, I. Kriţaj, F. Gubenšek, T. Turk, P. Maček, 
Primary and secondary structure of a pore-forming toxin from the sea anemone, Actinia 
equina L., and its association with lipid vesicles, Biochim. Biophys. Acta, 1192 (1994) 197-
204. 
[27] W. Zhang, M.G. Hinds, G. Anderluh, P.E. Hanse, R.S. Norton, Letter to the editor: 
Sequence-specific resonance assignments of the potent cytolysin equinatoxin II, J Biomol 
NMR, 18 (2000) 281-282. 
[28] M.G. Hinds, W. Zhang, G. Anderluh, P.E. Hansen, R.S. Norton, Solution structure of the 
eukaryotic pore-forming cytolysin equinatoxin II: implications for pore formation, J. Mol. 
Biol., 315 (2002) 1219-1229. 
[29] A. Athanasiadis, G. Anderluh, P. Maček, D. Turk, Crystal structure of the soluble form 
of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina, Structure, 9 
(2001) 341-346. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 29 
[30] N. Poklar, J. Fritz, P. Maček, G. Vesnaver, T.V. Chalikian, Interaction of the pore-
forming protein equinatoxin II with model lipid membranes: A calorimetric and spectroscopic 
study, Biochemistry, 38 (1999) 14999-15008. 
[31] G. Menestrina, V. Cabiaux, M. Tejuca, Secondary structure of sea anemone cytolysins in 
soluble and membrane bound form by infrared spectroscopy, Biochem. Biophys. Res. 
Commun., 254 (1999) 174-180. 
[32] G. Anderluh, A. Barlič, Z. Podlesek, P. Maček, J. Pungerčar, F. Gubenšek, M.L. 
Zecchini, M. Dalla Serra, G. Menestrina, Cysteine-scanning mutagenesis of an eukaryotic 
pore-forming toxin from sea anemone: topology in lipid membranes, Eur. J. Biochem., 263 
(1999) 128-136. 
[33] P. Malovrh, G. Viero, M.D. Serra, Z. Podlesek, J.H. Lakey, P. Maček, G. Menestrina, G. 
Anderluh, A novel mechanism of pore formation, J. Biol. Chem., 278 (2003) 22678-22685. 
[34] P. Malovrh, A. Barlič, Z. Podlesek, P. Maček, G. Menestrina, G. Anderluh, Structure-
function studies of tryptophan mutants of equinatoxin II, a sea anemone pore-forming protein, 
Biochem. J., 346 (2000) 223-232. 
[35] Q. Hong, I. Gutierrez-Aguirre, A. Barlič, P. Malovrh, K. Kristan, Z. Podlesek, P. Maček, 
D. Turk, J.M. Gonzalez-Manas, J.H. Lakey, G. Anderluh, Two-step membrane binding by 
equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic 
cluster and a flexible helix, J. Biol. Chem., 277 (2002) 41916-41924. 
[36] A. Drechsler, C. Potrich, J.K. Sabo, M. Frisanco, G. Guella, M. Dalla Serra, G. 
Anderluh, F. Separovic, R.S. Norton, Structure and activity of the N-terminal region of the 
eukaryotic cytolysin equinatoxin II, Biochemistry, 45 (2006) 1818-1828. 
[37] K. Kristan, G. Viero, P. Maček, M. Dalla Serra, G. Anderluh, The equinatoxin N-
terminus is transferred across planar lipid membranes and helps to stabilize the 
transmembrane pore, FEBS J., 274 (2007) 539-550. 
[38] K. Kristan, Z. Podlesek, V. Hojnik, I. Gutierrez-Aguirre, G. Gunčar, D. Turk, J.M. 
Gonzalez-Manas, J.H. Lakey, P. Maček, G. Anderluh, Pore formation by equinatoxin, a 
eukaryotic pore-forming toxin, requires a flexible N-terminal region and a stable β-sandwich, 
J. Biol. Chem., 279 (2004) 46509-46517. 
[39] N. Rojko, K.C. Kristan, G. Viero, E. Ţerovnik, P. Maček, M. Dalla Serra, G. Anderluh, 
Membrane damage by an α-helical pore-forming protein, equinatoxin II, proceeds through a 
succession of ordered steps, J. Biol. Chem., 288 (2013) 23704-23715. 
[40] J.B. Hayter, R.R. Highfield, B.J. Pullman, R.K. Thomas, A.I. McMullen, J. Penfold, 
Critical reflection of neutrons - a new technique for investigating interfacial phenomena, J. 
Chem. Soc. Faraday Trans. I, 77 (1981) 1437-1448. 
[41] H.P. Wacklin, Interfacial Mechanism of Phospholipase A(2): pH-Dependent Inhibition 
and Me-β-cyclodextrin Activation, Biochemistry, (2009). 
[42] M. Cardenas, H. Wacklin, R.A. Campbell, T. Nylander, Structure of DNA-cationic 
surfactant complexes at hydrophobically modified and hydrophilic silica surfaces as revealed 
by neutron reflectometry, Langmuir, 27 (2011) 12506-12514. 
[43] A. Michanek, M. Yanez, H. Wacklin, A. Hughes, T. Nylander, E. Sparr, RNA and DNA 
Association to zwitterionic and charged monolayers at the air liquid interface, Langmuir, 28 
(2012) 9621-9633. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 30 
[44] H.P. Wacklin, Neutron reflection from supported lipid membranes, Curr. Opin. Colloid 
Interface Sci., 15 (2010) 445-454. 
[45] H.P. Wacklin, Composition and asymmetry in supported membranes formed by vesicle 
fusion, Langmuir, 27 (2011) 7698-7707. 
[46] L.A. Clifton, C.L. Johnson, A.S. Solovyova, P. Callow, K.L. Weiss, H. Ridley, A.P. Le 
Brun, C.J. Kinane, J.R. Webster, S.A. Holt, J.H. Lakey, Low resolution structure and 
dynamics of a colicin-receptor complex determined by neutron scattering, J. Biol. Chem., 287 
(2012) 337-346. 
[47] A. Chenal, L. Prongidi-Fix, A.l. Perier, C. Aisenbrey, G.g. Vernier, S. Lambotte, G. 
Fragneto, B. Bechinger, D. Gillet, V. Forge, M. Ferrand, Deciphering Membrane Insertion of 
the Diphtheria Toxin T Domain by Specular Neutron Reflectometry and Solid-State NMR 
Spectroscopy, J. Mol. Biol., 391 (2009) 872-883. 
[48] D.J. McGillivray, G. Valincius, F. Heinrich, J.W.F. Robertson, D.J. Vanderah, W. Febo-
Ayala, I. Ignatjev, M. Losche, J.J. Kasianowicz, Structure of Functional Staphylococcus 
aureus α-Hemolysin Channels in Tethered Bilayer Lipid Membranes, Biophys. J., 96 (2009) 
1547-1553. 
[49] G. Anderluh, J. Pungerčar, B. Štrukelj, P. Maček, F. Gubenšek, Cloning, sequencing, and 
expression of equinatoxin II, Biochem. Biophys. Res. Commun., 220 (1996) 437-442. 
[50] B. Leiting, F. Marsilio, J.F. O'Connell, Predictable Deuteration of Recombinant Proteins 
Expressed in Escherichia coli, Anal. Biochem., 265 (1998) 351-355. 
[51] S.L. Grage, A.M. Keleshian, T. Turdzeladze, A.R. Battle, W.C. Tay, R.P. May, S.A. 
Holt, S.A. Contera, M. Haertlein, M. Moulin, P. Pal, P.R. Rohde, V.T. Forsyth, A. Watts, 
K.C. Huang, A.S. Ulrich, B. Martinac, Bilayer-mediated clustering and functional interaction 
of MscL channels, Biophys. J., 100 (2011) 1252-1260. 
[52] M.G. Cuypers, S.A. Mason, M.P. Blakeley, E.P. Mitchell, M. Haertlein, V.T. Forsyth, 
Near-atomic resolution neutron crystallography on perdeuterated Pyrococcus furiosus 
rubredoxin: implication of hydronium ions and protonation state equilibria in redox changes, 
Angew. Chem. Int. Ed. Engl., 52 (2013) 1022-1025. 
[53] N. Brouette, G. Fragneto, F. Cousin, M. Moulin, M. Haertlein, M. Sferrazza, A neutron 
reflection study of adsorbed deuterated myoglobin layers on hydrophobic surfaces, J. Colloid 
Inter. Sci., 390 (2013) 114-120. 
[54] J.B. Artero, M. Hartlein, S. McSweeney, P. Timmins, A comparison of refined X-ray 
structures of hydrogenated and perdeuterated rat gammaE-crystallin in H2O and D2O, Acta 
Crystallogr. D Biol. Crystallogr., 61 (2005) 1541-1549. 
[55] D. Bauza, Chapter 2 - Thermal Oxidation of Silicon and Si-SiO2 Interface Morphology, 
Structure and Localized States, in: H.S. Nalwa (Ed.) Handbook of Surfaces and Interfaces of 
Materials, Academic Press, Burlington, 2001, pp. 115-216. 
[56] A. Akesson, T. Lind, N. Ehrlich, D. Stamou, H. Wacklin, M. Cardenas, Composition and 
structure of mixed phospholipid supported bilayers formed by POPC and DPPC, Soft Matter, 
8 (2012) 5658-5665. 
[57] R. Cubitt, G. Fragneto, D17: the new reflectometer at the ILL, Applied Phys. Mat. Sci. 
Proc., 74 (2002) S329-S331. 
[58] H.P. Vacklin, F. Tiberg, G. Fragneto, R.K. Thomas, Composition of supported model 
membranes determined by neutron reflection, Langmuir, 21 (2005) 2827-2837. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 31 
[59] H.P. Vacklin, F. Tiberg, G. Fragneto, R.K. Thomas, Phospholipase A2 hydrolysis of 
supported phospholipid bilayers: a neutron reflectivity and ellipsometry study, Biochemistry, 
44 (2005) 2811-2821. 
[60] A. Nelson, Co-refinement of multiple-contrast neutron/X-ray reflectivity data using 
MOTOFIT, J. Appl. Crystallogr., 39 (2006) 273-276. 
[61] R.S. Armen, O.D. Uitto, S.E. Feller, Phospholipid component volumes: Determination 
and application to bilayer structure calculations, Biophys. J., 75 (1998) 734-744. 
[62] A.A. Zamyatin, Protein volume in solution, Prog. Biophys. Mol. Biol., 24 (1972) 107-
123. 
[63] C.H. Chen, S. Malkova, S.V. Pingali, F. Long, S. Garde, W. Cho, M.L. Schlossman, 
Configuration of PKCalpha-C2 domain bound to mixed SOPC/SOPS lipid monolayers, 
Biophys J, 97 (2009) 2794-2802. 
[64] B. Bakrač, I. Gutiérrez-Aguirre, Z. Podlesek, A.F.-P. Sonnen, R.J.C. Gilbert, P. Maček, 
J.H. Lakey, G. Anderluh, Molecular determinants of sphingomyelin specificity of a 
eukaryotic pore-forming toxin, J. Biol. Chem., 283 (2008) 18665-18677. 
[65] A.J. Miles, A. Drechsler, K. Kristan, G. Anderluh, R.S. Norton, B.A. Wallace, F. 
Separovic, The effects of lipids on the structure of the eukaryotic cytolysin equinatoxin II: a 
synchrotron radiation circular dichroism spectroscopic study, Biochim. Biophys. Acta, 1778 
(2008) 2091-2096. 
[66] C. Faure, L. Bonakdar, E.J. Dufourc, Determination of DMPC hydration in the Lα and 
Lβ′ phases by 2H solid state NMR of D2O, FEBS Lett., 405 (1997) 263-266. 
[67] C. Chachaty, D. Rainteau, C. Tessier, P.J. Quinn, C. Wolf, Building up of the liquid-
ordered phase formed by sphingomyelin and cholesterol, Biophys. J., 88 (2005) 4032-4044. 
[68] N. Kahya, D. Scherfeld, P. Schwille, Differential lipid packing abilities and dynamics in 
giant unilamellar vesicles composed of short-chain saturated glycerol-phospholipids, 
sphingomyelin and cholesterol, Chem. Phys. Lipids, 135 (2005) 169-180. 
[69] P.F.F. Almeida, A. Pokorny, A. Hinderliter, Thermodynamics of membrane domains, 
Biochim. Biophys. Acta - Biomembranes, 1720 (2005) 1-13. 
[70] G. Anderluh, M. Dalla Serra, G. Viero, G. Guella, P. Maček, G. Menestrina, Pore 
formation by equinatoxin II, a eukaryotic protein toxin, occurs by induction of nonlamellar 
lipid structures, J. Biol. Chem., 278 (2003) 45216-45223. 
[71] B.B. Bonev, Y.H. Lam, G. Anderluh, A. Watts, R.S. Norton, F. Separovic, Effects of the 
eukaryotic pore-forming cytolysin equinatoxin II on lipid membranes and the role of 
sphingomyelin, Biophys. J., 84 (2003) 2382-2392. 
[72] G. Anderluh, A. Razpotnik, Z. Podlesek, P. Maček, F. Separovic, R.S. Norton, 
Interaction of the eukaryotic pore-forming cytolysin equinatoxin II with model membranes: 
19
F NMR studies, J. Mol. Biol., 347 (2005) 27-39. 
[73] J.M. Caaveiro, I. Echabe, I. Gutierrez-Aguirre, J.L. Nieva, J.L. Arrondo, J.M. Gonzalez-
Manas, Differential interaction of equinatoxin II with model membranes in response to lipid 
composition, Biophys. J., 80 (2001) 1343-1353. 
[74] A. Barlič, I. Gutiérrez-Aguirre, J.M.M. Caaveiro, A. Cruz, M.-B. Ruiz-Argüello, J. 
Pérez-Gil, J.M. González-Mañas, Lipid Phase Coexistence favors membrane insertion of 
equinatoxin-ii, a pore-forming toxin from Actinia equina, J. Biol. Chem., 279 (2004) 34209-
34216. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 32 
[75] N. Rojko, B. Cronin, J.S. Danial, M.A. Baker, G. Anderluh, M.I. Wallace, Imaging the 
lipid-phase-dependent pore formation of equinatoxin II in droplet interface bilayers, Biophys. 
J., 106 (2014) 1630-1637. 
[76] A.J. García-Sáez, S.B. Buschhorn, H. Keller, G. Anderluh, K. Simons, P. Schwille, 
Oligomerization and pore formation by equinatoxin ii inhibit endocytosis and lead to plasma 
membrane reorganization, J. Biol. Chem., 286 (2011) 37768-37777. 
[77] B. Bakrač, A. Kladnik, P. Maček, G. McHaffie, A. Werner, J.H. Lakey, G. Anderluh, A 
toxin-based probe reveals cytoplasmic exposure of Golgi sphingomyelin, J. Biol. Chem., 285 
(2010) 22186-22195. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 33 
Figures 
 
Figure 1 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 34 
Figure 2 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 35 
Figure 3 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 36 
Figure 4 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 37 
Figure 5 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 38 
Figure 6 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 39 
Figure 7 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 40 
 
Graphical abstract 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 41 
Highlights 
 
 Equinatoxin II has several modes of membrane binding depending on lipid composition 
 Equinatoxin II binds in a different orientation to DMPC-sphingomyelin compared with 
pure DMPC 
 Phase-separation promotes pore formation in DMPC-SM-cholesterol membranes 
 In situ release of the N-terminal α-helix confirms its role in pore formation 
